Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute for Extracorporeal Life Support (I-ECLS) is a specialized organization dedicated to the advancement of extracorporeal membrane oxygenation (ECMO) and other life-support technologies. It provides comprehensive clinical training, simulation-based education, and research support for healthcare professionals managing patients with severe cardiac and respiratory failure. Founded with the goal of standardizing ECLS practices, the institute offers certification programs and consulting services to hospitals worldwide. Its work focuses on improving patient outcomes through technical proficiency and evidence-based protocols in the field of critical care. The organization serves as a hub for innovation and collaboration among specialists in the extracorporeal life support community.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Institute for Extracorporeal Life Support.